MAMelina Acevedo

Melina Acevedo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Melina Acevedo has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • A Decade of Pediatric Ventricular Assist Device Support in Colombia, a Middle‐Income Country

    by Javier Castro, Melina Acevedo, Angelica Ortiz, Juliana Ballesteros, Silvia Plata, Anne I. Dipchand, Claudia Florez, Sara Mendoza, Maria Constanza Basto, Alvaro Duran, et al.

    Background: Heart transplantation is the main treatment for refractory end‐stage heart failure in patients of all ages, but its use is limited by the availability of organs, especially in pediatric populations. The International Hospital of Colombia has been a pioneer and the single center with the capability in the country for providing ventricular assist device (VAD) support using the CentriMag/PediMag‐Levitronix paracorporeal VAD for pediatric patients awaiting transplant, with over a decade of experience albeit with many challenges. Methods: This retrospective study examines outcomes from 26 pediatric patients who received VAD support between 2012 and 2023. Results: Most patients were diagnosed with dilated cardiomyopathy ( n = 20, 77%), had an average age of 8.5 years (SD 5.3), and ranged in weight from 5 to 59 kg. The median duration of VAD support was 50.5 days, with 17 (81%) of surviving patients ( n = 21), successfully undergoing transplantation. Neurological injury was the most common complication, affecting 69% of patients. The overall survival rate to VAD support was 81% and patients with left ventricular assist devices (LVAD) showed a higher post‐transplant survival rate compared to those with biventricular assist devices (BiVAD). Conclusions: This comparative analysis highlights the challenges faced in Colombia, particularly in implementing advanced medical technologies in middle‐income countries. Despite these constraints, the study demonstrates notable patient survival, suggesting that targeted efforts to improve resource allocation and technology access could further enhance results.

  • Open Access

    Understanding the Challenge of Complex Congenital Heart Palliation Follow-Up in a Middle-Income Latin American Country

    by Laura Mantilla, Javier Castro, Silvia Plata, Doris Cristina Quintero-Lesmes, Melina Acevedo, Anderson Bermon, Claudia Flórez, Maria Constanza Basto, Juan Carlos Uribe Caputi

    Introduction. Congenital heart disease of great complexity like single ventricle are the most prevalent congenital defects, managing these requires multiple surgical procedures, usually three stages. Lethality during the interstage period has decreased due to practices as home monitoring. Given the significant resources invested in patient care, it is essential to improve long-term outcomes. There is limited research in cardiovascular disease within middle-income countries. Objective. To identify factors associated with lack of medical follow-up and lethality in children during first interstage period. Method. A retrospective cohort study was conducted including 173 children in their first interstage period after cardiovascular surgery for severe congenital heart disease. Reviewed clinical records and contacted caregivers through telephone/instant messaging software. Analysis included central tendency and dispersion measures. Associations between independent variables and the primary outcomes —loss to follow-up (LTF) and mortality during the interstage period— were evaluated using the Mann-Whitney, Chi-square or Fisher's exact tests. Results. Of 173 patients, 65 (37.6%) patients LTF. The risk factors for LTF: rural residence (OR=5.05, CI95%1.32-19.26), lower educational level of parents. Global lethality was 13.3% (CI95%7.9-20.4) and factors associated were: rural origin (OR=22.78, CI95%3.68-140.83), malnutrition (OR=25.47, CI95%2.96-218.73), necrotizing enterocolitis (OR=13.34, CI95%2.34-75.97) and heterotaxia or situs inversus (OR=8.05, CI95%1.26-51.34). The number of visits were a protective factor for interstage lethality (OR=0.71, CI95%0.55-0.9). Conclusion. The interstage period entails significant challenges for patients and their families, which are possibly exacerbated by the socio-economic context of a middle-income country. Improving follow-up and support for caregivers of patients under similar conditions could help mitigate identified factors related to lethality.


  • Open Access

    Switch después del Switch. Reentrenamiento como alternativa ante trasplante cardiaco

    by Javier Castro, Sara Mendoza, Melina Acevedo, Claudia Florez

    La transposición de grandes vasos (Dextro-TGA), reparada con técnicas de corrección fisiológica (switch atrial o cirugías de Mustard o Senning), puede presentar como complicación la falla del ventrículo derecho que funge como sistémico, y al mismo tiempo desacondicionamiento del ventrículo izquierdo, llevando a la insuficiencia cardiaca. En estos pacientes las opciones de tratamiento y recuperación son muy limitadas.Objetivo: Describir la corrección anatómica tardía exitosa después de reentrenamiento ventricular.Caso Clínico: Paciente con diagnóstico de Dextro-TGA, con múltiples complicaciones perinatales, operado con cirugía de Mustard a los 7 meses, quien evolucionó con falla cardiaca refractaria en el postoperatorio. Ante la opción de trasplante cardiaco, se decidió cerclaje pulmonar a los 11 meses de edad como medida de estabilización, que posteriormente permitió reentrenar el ventrículo izquierdo y llevar a la corrección anatómica con desmonte del Mustard y switch de grandes arterias exitoso a los 6 años. Tres años después, mantiene buena calidad de vida y clase funcional II. Conclusiones: En casos seleccionados como el descrito, el reentrenamiento ventricular puede ser una opción válida para los pacientes con dextro-TGA, en quienes previamente se realizó una corrección fisiológica y que evolucionaron con disfunción ventricular derecha (sistémica).